Texas 2025 89th Regular

Texas Senate Bill SB1619 Enrolled / Fiscal Note

Filed 05/05/2025

Download
.pdf .doc .html
                    LEGISLATIVE BUDGET BOARD     Austin, Texas       FISCAL NOTE, 89TH LEGISLATIVE REGULAR SESSION             May 1, 2025       TO: Honorable Dan Patrick, Lieutenant Governor, Senate     FROM: Jerry McGinty, Director, Legislative Budget Board      IN RE: SB1619 by Zaffirini (Relating to the use of an epinephrine delivery device by certain entities.), As Passed 2nd House     No significant fiscal implication to the State is anticipated. It is assumed that any costs associated with the bill could be absorbed using existing resources.  Local Government ImpactNo significant fiscal implication to units of local government is anticipated.  Source Agencies: b > td > 405 Department of Public Safety, 407 Commission on Law Enforcement, 503 Texas Medical Board, 515 Board of Pharmacy, 529 Health and Human Services Commission, 537 State Health Services, Department of, 701 Texas Education Agency, 710 Texas A&M University System Administrative and General Offices, 720 The University of Texas System Administration  LBB Staff: b > td > JMc, NPe, THO, NT

LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 89TH LEGISLATIVE REGULAR SESSION
May 1, 2025



TO: Honorable Dan Patrick, Lieutenant Governor, Senate     FROM: Jerry McGinty, Director, Legislative Budget Board      IN RE: SB1619 by Zaffirini (Relating to the use of an epinephrine delivery device by certain entities.), As Passed 2nd House

TO: Honorable Dan Patrick, Lieutenant Governor, Senate
FROM: Jerry McGinty, Director, Legislative Budget Board
IN RE: SB1619 by Zaffirini (Relating to the use of an epinephrine delivery device by certain entities.), As Passed 2nd House



Honorable Dan Patrick, Lieutenant Governor, Senate

Honorable Dan Patrick, Lieutenant Governor, Senate

Jerry McGinty, Director, Legislative Budget Board

Jerry McGinty, Director, Legislative Budget Board

SB1619 by Zaffirini (Relating to the use of an epinephrine delivery device by certain entities.), As Passed 2nd House

SB1619 by Zaffirini (Relating to the use of an epinephrine delivery device by certain entities.), As Passed 2nd House

No significant fiscal implication to the State is anticipated.

No significant fiscal implication to the State is anticipated.

It is assumed that any costs associated with the bill could be absorbed using existing resources.

Local Government Impact

No significant fiscal implication to units of local government is anticipated.

Source Agencies: b > td > 405 Department of Public Safety, 407 Commission on Law Enforcement, 503 Texas Medical Board, 515 Board of Pharmacy, 529 Health and Human Services Commission, 537 State Health Services, Department of, 701 Texas Education Agency, 710 Texas A&M University System Administrative and General Offices, 720 The University of Texas System Administration



405 Department of Public Safety, 407 Commission on Law Enforcement, 503 Texas Medical Board, 515 Board of Pharmacy, 529 Health and Human Services Commission, 537 State Health Services, Department of, 701 Texas Education Agency, 710 Texas A&M University System Administrative and General Offices, 720 The University of Texas System Administration

LBB Staff: b > td > JMc, NPe, THO, NT



JMc, NPe, THO, NT